This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Slovut, D. P. Articles by Sullivan, T. M Search for Related Content PubMed PubMed Citation Articles by Slovut, D. P. Articles by Sullivan, T. M Pubmed/NCBI databases Medline Plus Health Information Peripheral Arterial Disease Social Bookmarking                         What's this?

Critical limb ischemia: medical and surgical management

North Shore Medical Center, Salem, MA, USA david.slovut{at}mssm.edu

Timothy M Sullivan

Vascular and Endovascular Surgery, Minneapolis Heart Institute, Minneapolis, MN, USA

Abstract

Chronic critical limb ischemia (CLI), defined as > 2 weeks of rest pain, ulcers, or tissue loss attributed to arterial occlusive disease, is associated with great loss of both limb and life. Therapeutic goals in treating patients with CLI include reducing cardiovascular risk factors, relieving ischemic pain, healing ulcers, preventing major amputation, improving quality of life and increasing survival. These aims may be achieved through medical therapy, revascularization, or amputation. Medical therapy includes administration of analgesics, local wound care and pressure relief, treatment of infection, and aggressive therapy to modify atherosclerotic risk factors. For patients who are not candidates for revascularization, and who are unwilling or unable to undergo amputation, treatments such as intermittent pneumatic compression or spinal cord stimulation may offer symptom relief and promote wound healing. Revascularization offers the best option for limb salvage. The decision to perform surgery, endovascular therapy, or a combination of the two modalities (‘hybrid' therapy) must be individualized. Patients who are relatively fit and able to withstand the rigors of an open procedure may benefit from the long-term durability of surgical repair. In contrast, frail patients with a limited life expectancy may experience better outcomes with endovascular reconstruction. Hybrid therapy is an attractive option for patients with limited autologous conduit, as it permits complete revascularization with a less extensive procedure, shorter duration of operation, and decreased risk of peri-operative complications. Amputation should be considered for patients who are non-ambulatory, demented, or unfit to undergo revascularization.

Key Words: critical limb ischemia • medical therapy • revascularization

Vascular Medicine, Vol. 13, No. 3, 281-291 (2008)
DOI: 10.1177/1358863X08091485


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. Roy, S. Biswas, S. Khanna, G. Gordillo, V. Bergdall, J. Green, C. B. Marsh, L. J. Gould, and C. K. Sen Characterization of a preclinical model of chronic ischemic wound Physiol Genomics, May 13, 2009; 37(3): 211 - 224. [Abstract] [Full Text] [PDF]